1. Home
  2. XLO vs KLXE Comparison

XLO vs KLXE Comparison

Compare XLO & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • KLXE
  • Stock Information
  • Founded
  • XLO 2016
  • KLXE 2018
  • Country
  • XLO United States
  • KLXE United States
  • Employees
  • XLO N/A
  • KLXE N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • XLO Health Care
  • KLXE Energy
  • Exchange
  • XLO Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • XLO 35.7M
  • KLXE 35.8M
  • IPO Year
  • XLO 2021
  • KLXE N/A
  • Fundamental
  • Price
  • XLO $0.75
  • KLXE $1.81
  • Analyst Decision
  • XLO Buy
  • KLXE
  • Analyst Count
  • XLO 2
  • KLXE 0
  • Target Price
  • XLO $3.00
  • KLXE N/A
  • AVG Volume (30 Days)
  • XLO 946.5K
  • KLXE 86.8K
  • Earning Date
  • XLO 11-06-2025
  • KLXE 10-30-2025
  • Dividend Yield
  • XLO N/A
  • KLXE N/A
  • EPS Growth
  • XLO N/A
  • KLXE N/A
  • EPS
  • XLO N/A
  • KLXE N/A
  • Revenue
  • XLO $15,001,000.00
  • KLXE $667,400,000.00
  • Revenue This Year
  • XLO $982.12
  • KLXE N/A
  • Revenue Next Year
  • XLO N/A
  • KLXE $3.97
  • P/E Ratio
  • XLO N/A
  • KLXE N/A
  • Revenue Growth
  • XLO 536.45
  • KLXE N/A
  • 52 Week Low
  • XLO $0.62
  • KLXE $1.46
  • 52 Week High
  • XLO $1.70
  • KLXE $7.40
  • Technical
  • Relative Strength Index (RSI)
  • XLO 60.31
  • KLXE 46.55
  • Support Level
  • XLO $0.71
  • KLXE $1.73
  • Resistance Level
  • XLO $0.78
  • KLXE $1.94
  • Average True Range (ATR)
  • XLO 0.04
  • KLXE 0.12
  • MACD
  • XLO 0.01
  • KLXE -0.01
  • Stochastic Oscillator
  • XLO 64.03
  • KLXE 19.05

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: